|
1
|
Molecular biology of neuroblastoma.
|
J Clin Oncol
|
1999
|
6.54
|
|
2
|
The International Neuroblastoma Pathology Classification (the Shimada system).
|
Cancer
|
1999
|
6.42
|
|
3
|
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
|
J Pediatr Hematol Oncol
|
1999
|
3.35
|
|
4
|
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
|
J Clin Oncol
|
2005
|
2.97
|
|
5
|
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
|
J Clin Oncol
|
1996
|
1.94
|
|
6
|
Neuroblastoma in adults and adolescents: an indolent course with poor survival.
|
Cancer
|
1997
|
1.94
|
|
7
|
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.
|
J Clin Oncol
|
2000
|
1.79
|
|
8
|
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
|
Oncogene
|
1999
|
1.79
|
|
9
|
Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy.
|
Neuropsychology
|
2000
|
1.76
|
|
10
|
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
|
J Clin Oncol
|
2000
|
1.74
|
|
11
|
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group.
|
Cancer
|
1997
|
1.63
|
|
12
|
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
|
Cancer
|
2001
|
1.58
|
|
13
|
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
|
Med Pediatr Oncol
|
2001
|
1.58
|
|
14
|
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
|
Am J Pathol
|
1997
|
1.44
|
|
15
|
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
|
J Clin Oncol
|
2000
|
1.44
|
|
16
|
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
|
J Clin Oncol
|
1995
|
1.42
|
|
17
|
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
|
J Clin Oncol
|
2000
|
1.42
|
|
18
|
Response of neuroblastoma to retinoic acid in vitro and in vivo.
|
Prog Clin Biol Res
|
1991
|
1.41
|
|
19
|
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
|
J Clin Oncol
|
2000
|
1.40
|
|
20
|
The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.
|
J Endocrinol Invest
|
1997
|
1.39
|
|
21
|
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.
|
J Clin Oncol
|
2000
|
1.33
|
|
22
|
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
|
Eur J Cancer
|
1997
|
1.30
|
|
23
|
Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment.
|
Cancer
|
1988
|
1.25
|
|
24
|
Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
|
Infect Immun
|
1981
|
1.24
|
|
25
|
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.
|
Biochim Biophys Acta
|
1992
|
1.22
|
|
26
|
Daycare attendance and risk of childhood acute lymphoblastic leukaemia.
|
Br J Cancer
|
2002
|
1.16
|
|
27
|
Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
|
Br J Cancer
|
2000
|
1.11
|
|
28
|
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
|
Cancer
|
2001
|
1.11
|
|
29
|
Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis.
|
AJR Am J Roentgenol
|
2001
|
1.10
|
|
30
|
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
|
Int J Cancer
|
2001
|
1.10
|
|
31
|
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.
|
Br J Cancer
|
2009
|
1.10
|
|
32
|
Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
|
Arch Ophthalmol
|
2001
|
1.09
|
|
33
|
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
|
Br J Cancer
|
2012
|
1.09
|
|
34
|
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
|
Q J Nucl Med Mol Imaging
|
2008
|
1.08
|
|
35
|
Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.
|
Proc Natl Acad Sci U S A
|
1992
|
1.08
|
|
36
|
Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG.
|
J Nucl Med
|
2001
|
1.06
|
|
37
|
Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia.
|
Int J Radiat Oncol Biol Phys
|
1992
|
1.02
|
|
38
|
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
|
J Natl Cancer Inst
|
1995
|
1.02
|
|
39
|
Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.
|
J Pediatr
|
2001
|
1.00
|
|
40
|
Loss of heterozygosity for chromosome 14q in neuroblastoma.
|
Med Pediatr Oncol
|
2001
|
0.97
|
|
41
|
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
|
Med Pediatr Oncol
|
2001
|
0.96
|
|
42
|
Stage 4S neuroblastoma: what makes it special?
|
J Clin Oncol
|
1998
|
0.95
|
|
43
|
Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia.
|
J Pediatr
|
1984
|
0.92
|
|
44
|
Toxicities of total-body irradiation for pediatric bone marrow transplantation.
|
Int J Radiat Oncol Biol Phys
|
1996
|
0.90
|
|
45
|
Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
|
J Pediatr Surg
|
1995
|
0.89
|
|
46
|
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
|
Med Pediatr Oncol
|
2001
|
0.89
|
|
47
|
Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
|
J Clin Oncol
|
1996
|
0.88
|
|
48
|
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.
|
J Pediatr Hematol Oncol
|
2000
|
0.88
|
|
49
|
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
|
Med Pediatr Oncol
|
2001
|
0.87
|
|
50
|
MYCN expression in neuroblastoma: A mixed message?
|
J Clin Oncol
|
2000
|
0.86
|
|
51
|
Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition.
|
Cancer Res
|
1987
|
0.86
|
|
52
|
Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization.
|
J Pediatr
|
1983
|
0.85
|
|
53
|
Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience.
|
Ann Surg Oncol
|
1995
|
0.84
|
|
54
|
Bone marrow in children with acute lymphocytic leukemia: MR relaxation times.
|
Radiology
|
1986
|
0.84
|
|
55
|
Erythrocyte enzymopathies in the newborn.
|
Clin Haematol
|
1981
|
0.84
|
|
56
|
Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles.
|
Cancer Res
|
1984
|
0.84
|
|
57
|
131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.
|
Q J Nucl Med Mol Imaging
|
2013
|
0.83
|
|
58
|
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
|
Prog Clin Biol Res
|
1991
|
0.82
|
|
59
|
Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery.
|
Cancer Res
|
1986
|
0.81
|
|
60
|
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.
|
Med Pediatr Oncol
|
2000
|
0.80
|
|
61
|
Primary bone tumors: value of MR angiography for preoperative planning and monitoring response to chemotherapy.
|
AJR Am J Roentgenol
|
1995
|
0.80
|
|
62
|
Renal cell carcinoma after therapy for neuroblastoma.
|
AJR Am J Roentgenol
|
1996
|
0.80
|
|
63
|
Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.
|
J Nucl Med
|
1993
|
0.80
|
|
64
|
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
|
Cancer
|
2000
|
0.79
|
|
65
|
Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.
|
Med Pediatr Oncol
|
1998
|
0.79
|
|
66
|
Intraoperative radiation therapy for high-risk pediatric neuroblastoma.
|
Int J Radiat Oncol Biol Phys
|
2000
|
0.79
|
|
67
|
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors.
|
Med Pediatr Oncol
|
2000
|
0.79
|
|
68
|
Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas.
|
Int J Radiat Oncol Biol Phys
|
2001
|
0.79
|
|
69
|
Congenital leukemia: successful treatment of a newborn with t(5;11)(q31;q23).
|
J Pediatr Hematol Oncol
|
1999
|
0.78
|
|
70
|
Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
|
Radiology
|
1992
|
0.78
|
|
71
|
Childhood acute lymphoblastic leukemia.
|
Pediatr Ann
|
1988
|
0.78
|
|
72
|
Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.
|
Med Pediatr Oncol
|
2000
|
0.77
|
|
73
|
Telomerase expression in primary neuroblastomas.
|
Eur J Cancer
|
1997
|
0.77
|
|
74
|
Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography.
|
Med Pediatr Oncol
|
1996
|
0.76
|
|
75
|
Prenatal diagnosis of chronic granulomatous disease.
|
Am J Med Genet
|
1984
|
0.76
|
|
76
|
Somatization, anxiety and depression as measures of health-related quality of life of children/adolescents with cancer.
|
Int J Cancer Suppl
|
1999
|
0.76
|
|
77
|
Solid tumors in children.
|
N Engl J Med
|
1991
|
0.75
|
|
78
|
Role of radiotherapy in neuroblastoma.
|
J Clin Oncol
|
1991
|
0.75
|
|
79
|
Modification of hemoglobin H disease by sickle trait.
|
J Clin Invest
|
1979
|
0.75
|
|
80
|
A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma.
|
Cancer
|
2000
|
0.75
|
|
81
|
Monoclonal antibodies in the diagnosis and treatment of childhood diseases.
|
Adv Pediatr
|
1985
|
0.75
|
|
82
|
Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG).
|
Horm Metab Res
|
2012
|
0.75
|
|
83
|
Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.
|
Horm Res
|
1998
|
0.75
|
|
84
|
Hematologic disorders affecting the lungs.
|
Clin Chest Med
|
1989
|
0.75
|
|
85
|
Antibody-directed liposomes: the development of a cell-specific cytotoxic agent.
|
Biochem Soc Trans
|
1984
|
0.75
|
|
86
|
Intracranial hemorrhage in congenital factor VII deficiency.
|
J Pediatr
|
1979
|
0.75
|
|
87
|
Total body irradiation and bone marrow transplantation for immunodeficiency disorders in young children.
|
Radiother Oncol
|
1990
|
0.75
|
|
88
|
Spinal cord compression in a child with acute lymphoblastic leukemia.
|
Am J Pediatr Hematol Oncol
|
1985
|
0.75
|
|
89
|
Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia.
|
Blood
|
1989
|
0.75
|
|
90
|
Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma.
|
J Clin Oncol
|
1993
|
0.75
|
|
91
|
Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.
|
Clin Nucl Med
|
1994
|
0.75
|
|
92
|
Radiological case of the month. Miliary pulmonary neuroblastoma.
|
Arch Pediatr Adolesc Med
|
1995
|
0.75
|
|
93
|
Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.
|
Prog Clin Biol Res
|
1994
|
0.75
|